Skip to main content
. Author manuscript; available in PMC: 2009 May 1.
Published in final edited form as: Urology. 2008 Mar 10;71(5):776–781. doi: 10.1016/j.urology.2007.11.154

Table 4.

Mean annual costs (5/02-4/03) by RxRisk quartile* (Lower quartile = fewer comorbidities)

RxRisk Quartile Cost Category No. Cases Mean ($) No. Controls Mean ($) p-value
I Pharmacy 62 1244 238 431 <0.0001
Outpatient 2015 950 <0.0001
Inpatient 947 528 0.506
Total 4206 1909 0.008
II Pharmacy 60 1515 247 544 <0.0001
Outpatient 2348 1212 <0.0001
Inpatient 2496 313 0.003
Total 6359 2070 <0.0001
III Pharmacy 58 2074 137 1266 0.004
Outpatient 3176 1320 <0.0001
Inpatient 1418 1441 0.984
Total 6667 4028 0.073
IV Pharmacy 43 3720 95 3101 0.349
Outpatient 4053 2655 0.030
Inpatient 2934 1077 0.091
Total 10,707 6832 0.023
*

RxRisk score based on comorbidities in prior year.